Challenges in optimizing the treatment of Pneumocystis pneumonia in the intensive care unit. Author's reply

Intensive Care Med. 2024 Oct;50(10):1721-1722. doi: 10.1007/s00134-024-07592-4. Epub 2024 Aug 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antifungal Agents / therapeutic use
  • Humans
  • Intensive Care Units* / organization & administration
  • Pneumocystis carinii
  • Pneumonia, Pneumocystis* / drug therapy

Substances

  • Antifungal Agents